Biotech Investing

Neurocrine and Xenon to Develop Treatments for Epilepsy

Biotech Investing

Akari Therapeutics Announces Phase 3 Trial Design

Biotech Investing

INmune Bio Doses First Alzheimer’s Disease Patient in XPro1595 Study

Biotech Investing

5 Top NASDAQ Biotech and Pharma Stocks: Sorrento Climbs

Biotech Investing

Naturally Splendid Reports Third Quarter Results

Cannabis Investing News

Lexaria Announces 2nd Tranche Closing of Non-Brokered Private Placement

Cannabis Investing News

Aravive Announces Pricing of Public Offering of Common Stock

Biotech Investing

Seelos Therapeutics Begins Dosing in Phase 1 PK/KD Study

Biotech Investing

Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

Cannabis Investing News

Naturally Splendid Provides Further Details on Producing Energy Bites for International Plant-Based Nutrition Company

Cannabis Investing News

Acasti Pharma Updates on TRILOGY 1 Phase 3 Trial

Biotech Investing

Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial

Biotech Investing

Latest biotech News

More biotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES